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Nucleocytoplasmic shuttling activity of the African swine fever virus p37 protein, a major structural protein
of this highly complex virus, has been recently reported. The systematic characterization of the nuclear export
ability of this protein constituted the major purpose of the present study. We report that both the N- and
C-terminal regions of p37 protein are actively exported from the nucleus to the cytoplasm of yeast and
mammalian cells. Moreover, experiments using leptomycin B and small interfering RNAs targeting the CRM1
receptor have demonstrated that the export of p37 protein is mediated by both the CRM1-dependent and
CRM1-independent nuclear export pathways. Two signals responsible for the CRM1-mediated nuclear export
of p37 protein were identified at the N terminus of the protein, and an additional signal was identified at the
C-terminal region, which mediates the CRM1-independent nuclear export. Interestingly, site-directed mu-
tagenesis revealed that hydrophobic amino acids are critical to the function of these three nuclear export
signals. Overall, our results demonstrate that two distinct pathways contribute to the strong nuclear export of
full-length p37 protein, which is mediated by three independent nuclear export signals. The existence of
overlapping nuclear export mechanisms, together with our observation that p37 protein is localized in the
nucleus at early stages of infection and exclusively in the cytoplasm at later stages, suggests that the nuclear
transport ability of this protein may be critical to the African swine fever virus replication cycle.
The control of the subcellular localization of proteins by
active nucleocytoplasmic transport mechanisms is essential for
the regulation of protein function in various biological pro-
cesses, such as the cell cycle or the replication cycle of several
viruses (42, 47, 49). The translocation of macromolecules
larger than 60 kDa into and out of the nucleus is an active,
energy-dependent process that is mediated by specific se-
quence motifs, nuclear localization signals (NLSs), and nuclear
export signals (NESs) (5, 18).
Classical examples of NESs include the motifs found in the
human immunodeficiency virus type 1 (HIV-1) Rev protein
(13) and in protein kinase inhibitor (PKI) (48), which are
characterized by clusters of four closely spaced hydrophobic
amino acids, such as leucine and isoleucine residues. However,
NESs that do not belong to the family of leucine-rich NESs
have also been described for various proteins, as exemplified
by the atypical NES present in the hepatitis D antigen
HDAg-L (27).
Direct interaction of proteins bearing leucine-rich NESs
with the nuclear export factor CRM1, also known as expor-
tin-1, is very well documented and essential for the active
nuclear export of these proteins (14, 15, 33, 44). Leptomycin B
(LMB), a metabolite that disrupts the interaction of NESs with
the CRM1 receptor by binding to a cysteine residue localized
in the central domain of the receptor, constitutes a useful
reagent for studying the CRM1-mediated protein nuclear ex-
port (25, 26). Although the CRM1-dependent transport is the
best-characterized nuclear export pathway, CRM1-indepen-
dent pathways have been proposed for various proteins (7, 27,
28).
Recently, we have described the African swine fever virus
(ASFV) p37 protein as the first nucleocytoplasmic shuttling
protein to be identified in this virus (12). Additionally, we have
demonstrated that the nuclear export of the ASFV p37 protein
is a very strong process.
African swine fever virus, the only member of the new virus
family Asfarviridae (9), is the causative agent of a highly lethal
hemorrhagic disease that affects domestic pigs (46). The ge-
nome of ASFV strain BA71V, a large linear double-stranded
DNA molecule, has been completely sequenced, and its anal-
ysis has identified 151 open reading frames, which encode
approximately 50 structural proteins and several enzymes in-
volved in viral DNA replication, viral gene transcription, and
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protein modification (45, 51). Autoradiography studies of
ASFV-infected macrophages, as well as in situ hybridization
experiments performed with ASFV-infected macrophages and
Vero cells, have demonstrated that viral DNA synthesis is
initiated inside the nucleus, followed by a longer replication
stage that occurs in the cytoplasm (16, 38). These observations
render the identification and characterization of the nucleocy-
toplasmic transport of ASFV proteins particularly interesting.
p37 protein, as well as p150, p34, and p14 ASFV proteins, is
a product of the proteolytic processing of the polyprotein pre-
cursor pp220 (41) by a viral protease that shares sequence
similarity with proteases of the SUMO-1 family (2). These viral
proteins are localized in the viral core shell domain, a matrix-
like domain which envelopes the DNA-containing nucleoid (1,
3). Interesting studies on the repression of the expression of
pp220 have demonstrated that this polyprotein precursor is
essential for viral core assembly and envelopment, as well as
for the subsequent steps of core formation, including DNA
encapsidation and nucleoid maturation (4).
In the present study, we provide evidence that the nuclear
export of the ASFV p37 protein is mediated both by the
CRM1-dependent and CRM1-independent nuclear export
pathways. Furthermore, we demonstrate that when considered
independently, these nuclear export pathways have compara-
ble strengths. Additionally, we have identified and character-
ized two NESs at the N terminus of p37 protein, which are
responsible for its nuclear export via the CRM1 pathway, as
well as an additional NES at the C terminus, which mediates
the CRM1-independent nuclear export. Finally, experiments
on the localization of p37 protein in ASFV-infected cells dem-
onstrate that at early stages of infection, the p37 protein is
localized in distinct nuclear regions and that at later stages, the
protein is localized exclusively in the cytoplasm. Overall, these
findings reinforce the importance of p37 protein nuclear trans-
port to the ASFV replication cycle.
MATERIALS AND METHODS
Plasmid constructs. GFP-expressing plasmids pNEAp37, pNEARev, GFPp37,
pRev(1.4)-GFP, and pRev(1.4)-NES were described previously (12, 19, 35).
The various fragments used for mapping the NESs of p37 were amplified by
PCR, using specific primers that introduced BamHI and NsiI recognition sites,
respectively, at the 5 and 3 ends of the amplified DNA sequences. Each DNA
fragment was cloned into the BamHI/PstI restriction sites of the plasmid for the
yeast nuclear export assay pNEA (35) and/or into pEGFP-C1 (Clontech).
Full-length p37 and the p37 fragments (amino acids 1 to 160, 158 to 234, 231
to 372) were amplified by PCR using specific primers, which introduced a 5
BamHI restriction site and a 3 AgeI restriction site, to facilitate cloning into
pRev(1.4)-GFP.
All the point and deletion mutants used throughout this study were generated
by PCR-based mutagenesis using the QuikChange site-directed mutagenesis kit
(Stratagene) according to the manufacturer’s instructions.
Proper framing and accuracy of sequence of all DNA constructs were con-
firmed by DNA sequencing.
All primers used in this study and construction details are available upon
request.
Purification of plasmid DNA for sequencing and transfection experiments was
performed using a plasmid midi kit (QIAGEN) according to the manufacturer’s
instructions.
Yeast nuclear export assay. The yeast nuclear export assay has been previously
described by Rhee et al. (35). Briefly, pNEA-derived constructs were trans-
formed into Saccharomyces cerevisiae strain L40, which contains the two LexA-
inducible genes HIS3 and lacZ (21), by the lithium acetate method (22). The
transformed yeast cells were then plated on selective medium without trypto-
phan. Since pNEA contains the TRP1 gene, only transformed yeast cells can
grow on this medium. After growth, a few colonies were spread on minimal
medium without tryptophan and in parallel plated on minimal medium deficient
in both tryptophan and histidine and supplemented with 10 mM 3-amino-1,2,4-
triazole (Sigma), a repressor of yeast endogenous histidine production (35). For
pNEARev, the minimal medium deficient in both tryptophan and histidine was
supplemented with 100 mM 3-amino-1,2,4-triazole (35). Yeast growth in the
absence of histidine was evaluated.
Additionally, yeast cells plated on tryptophan-deficient medium were trans-
ferred to nitrocellulose filters and assayed for -galactosidase activity (6). Briefly,
after disruption of yeast cell membrane by incubation at 70°C for 30 minutes,
yeast lysates were incubated with the -galactosidase substrate 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (X-Gal) (Sigma), and blue-color devel-
opment was evaluated.
For quantitative determination of -galactosidase activity, an enzymatic assay
was performed in liquid cultures (43). After growth in liquid medium without
tryptophan, yeast cells were disrupted, and the -galactosidase chromogenic
substrate o-nitrophenyl--D-galactopyranoside (ONPG; Sigma) was added in
excess. After incubation at 30°C, the reaction was stopped by raising the pH to
11, which inactivates -galactosidase. -galactosidase activity was calculated as
described previously (30).
Cell culture. Vero and COS-7 cells were grown and maintained in Dulbecco’s
modified Eagle’s medium-high glucose (DMEM-HG; Sigma) supplemented with
10% (vol/vol) heat-inactivated fetal bovine serum (FBS; Biochrom KG) and with
100 U of penicillin and 100 g of streptomycin (Sigma) per ml in a 5% CO2
humidified atmosphere at 37°C.
For the transfection and ASFV infection experiments, 7.5  104 Vero or
COS-7 cells were seeded onto glass coverslips on a 12-well plate.
Transfection, energy depletion, and leptomycin B treatment. Transfection
experiments were performed using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions, using 1 g of plasmid DNA per well. The cells
were incubated for 48 hours to allow gene expression.
For energy depletion studies, prior to fixation, the cells were incubated in
energy depletion medium composed of glucose-free DMEM (Invitrogen), 6 mM
2-deoxy-D-glucose (Sigma), and 10 mM sodium azide (Sigma) and supplemented
with 10% FBS (40) for 3 hours at 37°C.
Where indicated, the cells were incubated with 20 ng/ml leptomycin B (Sigma)
in DMEM-HG supplemented with 10% FBS for 3 hours prior to fixation.
CRM1 silencing experiments. The short interfering RNA (siRNA) duplex
used for depletion of the CRM1 receptor (CRM1 siRNA) [sense, UGUGGUG
AAUUGCUUAUACd(TT); antisense, GUAUAAGCAAUUCACCACAd(TT)]
(29), targeted to residues 90 to 108 of the human CRM1 receptor, and a
nonsilencing control siRNA were obtained from QIAGEN. Vero cells were
transfected at a confluence of 40 to 50% either on 12-well plates with 16-mm
coverslips (fluorescence microscopy) or on 35-mm dishes (Western blotting).
Cell transfection with siRNAs and simultaneous transfection with the green
fluorescent protein (GFP) fusion plasmids and siRNAs were performed using
Lipofectamine 2000 (Invitrogen) (10). The cells were harvested 48 hours post-
transfection, and analysis of the subcellular localization of the different p37
constructs was performed.
Efficient depletion of the CRM1 receptor by the CRM1 siRNA was confirmed
by Western blot analysis using the nonsilencing siRNA as a control.
Western blot analysis. Forty-eight hours posttransfection, Vero cells were
washed with phosphate-buffered saline (PBS) and lysed in sample buffer (62.5
mM Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate, 5% -mercaptoethanol, 10%
glycerol, and 0.01% bromophenol blue). After brief sonication, the samples were
heated to 95°C for 10 minutes. Total cell extracts were separated on a 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the resolved
proteins were transferred onto nitrocellulose membranes (Amersham Bio-
sciences). The blot was blocked with 5% (wt/vol) dried milk in Tris-buffered
saline plus Tween and then incubated overnight at 4°C with the rabbit polyclonal
anti-CRM1 antibody (Santa Cruz) or mouse monoclonal anti--tubulin antibody
(Sigma). After being washed three times with Tris-buffered saline plus Tween,
the membrane was incubated for 1 hour with alkaline phosphatase-conjugated
secondary antibodies. The blots were revealed by chemifluorescence (ECF; Am-
ersham).
Rev(1.4)-GFP nuclear export assay. To assess the strength of the nuclear
export activity of different fragments of p37 protein, the Rev(1.4)-GFP nuclear
export assay, described previously by Henderson and Eleftheriou (19), was used.
This assay is based on the ability of functional nuclear export sequences to
promote the nuclear export activity of the Rev(1.4)-GFP fusion protein, which is
composed of a NES-deficient mutant of the HIV-1 Rev protein and GFP.
The assay was performed in COS-7 cells as described previously (19). Briefly,
the cells were transfected with pRev(1.4)-GFP (negative control) or its derivative
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plasmids containing either the NES of the HIV-1 Rev protein (positive control)
or each of the sequences to be tested. Forty-eight hours posttransfection, all cell
samples were treated with 10 g/ml cycloheximide to ensure that any cytoplasmic
GFP fluorescence resulted only from the nuclear export of GFP fusion proteins
and not from de novo protein synthesis. Simultaneously, part of the cell samples
were treated for 3 hours with 5 g/ml actinomycin D (ActD), which is known to
specifically block the nuclear import of Rev protein by a mechanism not yet
elucidated. This treatment allows the detection of weak NESs, which would not
be detected if Rev protein nuclear import was occurring. The remaining cell
samples were treated with 20 ng/ml of LMB for 3 hours.
The nuclear export activity of the various tested sequences was determined
according to a scoring system, which is based on the proportion of cells showing
exclusively nuclear, both nuclear and cytoplasmic, or exclusively cytoplasmic
GFP fluorescence under the different experimental conditions (19). For this
purpose, the subcellular localization of each GFP fusion protein was determined
in at least 200 cells per experimental condition from three independent experi-
ments.
Immunofluorescence studies of ASFV-infected cells. The antibody against
ASFV p37 protein used for the immunofluorescence studies was obtained from
rabbits immunized with the synthetic peptide NLTHNKQEFQSYEENY, which
corresponds to amino acids 39 to 54 of this protein. The antibody was purified by
affinity chromatography (Eurogentec), and the specificity of the purified antibody
was characterized by Western blot and immunofluorescence analyses in ASFV-
infected Vero cells (data not shown).
Vero cells were infected with ASFV strain BA71V (11) at a multiplicity of
infection of 40 and 10 PFU/cell for immunofluorescence analysis at 6 (hours
postinfection) hpi and 14 hpi, respectively. Adsorption of ASFV to the cells was
performed for 2 hours at 4°C in DMEM-HG supplemented with 2% (vol/vol)
FBS and 25 mM HEPES (pH 7.4) with gentle stirring. Following adsorption, the
cells were washed thoroughly with DMEM-HG supplemented with 2% (vol/vol)
FBS, and the infections were allowed to progress at 37°C for the indicated times.
Following the incubation period, ASFV-infected cells were washed with PBS
and fixed with 4% paraformaldehyde for 15 minutes, followed by 5 minutes of
incubation in methanol at 20°C. The cells were then permeabilized with 0.2%
Triton X-100 for 5 minutes at room temperature, blocked with 3% bovine serum
albumin in PBS at room temperature for 30 minutes, and incubated for 1 hour
at room temperature with anti-p37 antibody diluted 1:500 and anti--tubulin
monoclonal antibody (Sigma) diluted 1:250 in blocking solution. After being
washed extensively with PBS, the cells were incubated for 1 hour at room
temperature with Alexa Fluor 488 goat anti-rabbit immunoglobulin G and Alexa
Fluor 594 goat anti-mouse immunoglobulin G antibodies (Molecular Probes)
diluted 1:500 in blocking solution. The cells were washed further, and coverslips
were mounted with Mowiol (Calbiochem) on glass slides.
Confocal fluorescence microscopy. For fluorescence microscopy analysis of
GFP fusion proteins, Vero or COS-7 cells were washed with PBS, fixed with 4%
paraformaldehyde for 15 minutes, and rinsed with PBS. The coverslips were then
inverted and mounted on glass slides with Vectashield mounting medium (Vec-
tor Laboratories).
Fluorescence observations were performed using either a Bio-Rad MRC 600
or a Bio-Rad Radiance 2000 fluorescence confocal microscope equipped with an
argon/krypton laser at a magnification of 600.
RESULTS
The N- and C-terminal fragments of p37 protein are ex-
ported from the nucleus to the cytoplasm of yeast and mam-
malian cells. As a first approach to identify the localization of
a functional nuclear export signal(s) within the ASFV p37
protein, the ability of three p37 fragments (amino acids 1 to 160,
158 to 234, and 231 to 372) to undergo nuclear export was eval-
uated using a yeast-based nuclear export assay (35). This assay is
based on the activation of two reporter genes (HIS3 and lacZ)
present in Saccharomyces cerevisiae strain L40 by a fusion pro-
tein encoded by pNEA, comprising mLexA (bacterial LexA
modified to inactivate its internal NLS), simian virus 40 (SV40)
NLS (SV40 large T-antigen NLS), Gal4AD (yeast Gal4p acti-
vation domain), and the protein sequence to be tested.
Figure 1a presents the results obtained for pNEA and
pNEARev, which were used as negative and positive controls
for the nuclear export assay, respectively. pNEA encodes the
mLexA-SV40NLS–Gal4AD fusion protein that is actively im-
ported into the nucleus but not exported, thus leading to max-
imal expression of the two reporter genes. pNEARev encodes
the fusion protein containing the HIV-1 Rev protein (35),
which is known to be exported from the nucleus due to the
presence of a strong leucine-rich NES. When expressed in
yeast cells, the fusion protein encoded by pNEARev was ac-
tively exported from the nucleus of yeast cells, thus preventing
the expression of the reporter genes. As a consequence, yeast
cells were not able to grow on histidine-deficient medium and
did not exhibit -galactosidase activity.
In a pattern identical to that observed for the positive con-
trol (pNEARev) and for full-length p37 protein (Fig. 1a) (12),
cells expressing pNEA encompassing amino acids 1 to 160
[pNEA(1-160)] and pNEA(231-372) did not grow on histidine-
deficient medium and expressed residual levels of -galactosi-
FIG. 1. Both the N and C termini of the ASFV p37 protein are
exported from the nucleus to the cytoplasm of yeast cells. (a) Growth
of L40 yeast transformed with the indicated constructs was analyzed
both on selective medium without tryptophan (His) and on medium
without tryptophan and histidine (His) as described in Materials and
Methods. -Galactosidase (-gal) activity was evaluated using the col-
ony-lift filter assay. (b) Quantitative -galactosidase activity was deter-
mined following cell growth in minimal medium deficient in trypto-
phan as described in Materials and Methods. Data are expressed as
percentages of maximal enzymatic activity obtained for pNEA alone
(negative control); standard deviations are shown based on quintupli-
cates for at least three independent experiments.
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dase (Fig. 1a). In contrast, yeast cells expressing pNEA(158-
234) showed both cell growth on histidine-deficient medium
and -galactosidase activity, indicating efficient activation of
the reporter HIS3 and lacZ genes (Fig. 1a).
Overall, these results demonstrate that both the N- and
C-terminal fragments of p37 protein are actively exported from
the nucleus to the cytoplasm of yeast cells and that the
p37(158-234) fragment is not exported.
A quantitative evaluation of -galactosidase activity in yeast
expressing the different constructs showed that yeast cells har-
boring pNEA(1-160) and pNEA(231-372), similar to those
harboring pNEARev and pNEAp37, presented significantly
lower levels of -galactosidase activity than those observed for
the negative control (pNEA) (Fig. 1b), further supporting the
ability of these p37 fragments to undergo nuclear export in
yeast cells.
To investigate their nuclear export activity in mammalian
cells, the subcellular localization of these three fragments
fused with GFP was analyzed in Vero cells by confocal fluo-
rescence microscopy.
Similar to what was observed for full-length p37 protein
(12), the GFP(1-160) and GFP(231-372) fusion proteins were
localized exclusively in the cytoplasm of transfected cells (Fig.
2a), strongly suggesting that these two p37 fragments are ex-
ported from the nucleus to the cytoplasm of mammalian cells.
Conversely, GFP(158-234) was present in both the cell cyto-
plasm and nucleus (Fig. 2a), indicating that this p37 fragment
is not actively exported from the nucleus to the cytoplasm of
mammalian cells. GFP alone was distributed throughout the
cell as a consequence of its low molecular weight, which allows
its passive diffusion within the cell (Fig. 2a).
To confirm that the exclusively cytoplasmic fluorescence ob-
served in cells expressing GFP(1-160) and GFP(231-372) was
due to active nuclear export rather than to cytoplasmic reten-
tion of the fusion proteins, their subcellular localization was
evaluated in energy-depleted cells. Under these experimental
conditions, the active Ran-dependent nucleocytoplasmic trans-
port processes are blocked whereas diffusion remains unaf-
fected (40).
As can be observed in Fig. 2b, energy depletion of cells
FIG. 2. The nuclear export of p37 protein is mediated by both the CRM1-dependent and CRM1-independent pathways. Subconfluent cultures
of Vero cells were transiently transfected with the plasmids encoding GFP, GFPp37, GFP(1-160), GFP(158-234), or GFP(231-372). Forty-eight
hours posttransfection, the subcellular localization of the different fusion proteins was visualized by fluorescence confocal microscopy (magnifi-
cation, 600) under different experimental conditions: (a) untreated cells; (b) cells incubated in energy depletion medium for 3 hours (ATP);
(c) cells treated with leptomycin B (20 ng/ml) for 3 hours (LMB); and (d) cells simultaneously transfected with siRNA for CRM1 depletion and
plasmids encoding the different GFP fusion proteins (CRM1 siRNA). Experiments were performed at least three times, and representative
images are shown. (e) Western blot analysis of CRM1 expression in Vero cells following transfection with siRNA for depletion of CRM1 (CRM1
siRNA) or with a nonsilencing control siRNA. Forty-eight hours after transfection, the cells were harvested, and Western blot analysis was
performed using anti-CRM1 and anti--tubulin antibodies as described in Materials and Methods.
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transfected with GFPp37, GFP(1-160), and GFP(231-372) re-
sulted in a significant increase of fluorescence inside the nu-
cleus, thus demonstrating that these fusion proteins are able to
diffuse between the cytoplasm and the nucleus and thereby
providing unequivocal evidence that the cytoplasmic localiza-
tion of the GFP(1-160) and GFP(231-372) fusion proteins in
nontreated cells is a consequence of active nuclear export.
Overall, the observations in mammalian cells are consistent
with the results obtained using the yeast-based nuclear export
assay, which collectively demonstrate that both the N- and
C-terminal regions of p37 protein are exported from the nu-
cleus to the cytoplasm. In addition, these findings clearly indi-
cate that p37 protein contains at least two independently func-
tional NESs.
The nuclear export of p37 protein is mediated by two dis-
tinct pathways, the CRM1-dependent and CRM1-independent
nuclear export pathways. We had previously observed that the
nuclear export of full-length p37 protein is inhibited by lepto-
mycin B (12), a metabolite that potently and specifically blocks
the CRM1-dependent nuclear export pathway by binding di-
rectly to a cysteine residue of the CRM1 receptor (25, 26), thus
demonstrating that the CRM1 pathway is involved in the nu-
clear export of p37 protein.
To investigate the contribution of the CRM1 pathway to the
nuclear export of the p37(1-160) and p37(231-372) fragments,
the effect of LMB on the subcellular localization of fusions of
these p37 fragments with GFP was analyzed. Treatment of
Vero cells with LMB had no effect on the subcellular distribu-
tion of GFP alone, whereas in cells expressing GFP(1-160),
such treatment resulted in a clear accumulation of the fusion
protein inside the nucleus (Fig. 2c). Interestingly, the subcel-
lular localization of the GFP(231-372) fusion protein was not
altered upon LMB treatment (Fig. 2c).
As an alternative approach to evaluate the involvement of
the CRM1 receptor in the nuclear export of these fragments,
RNA interference studies targeting the CRM1 receptor were
performed. For this purpose, the subcellular localization of
full-length p37 protein and p37 fragments was assessed in Vero
cells transfected simultaneously with an siRNA targeted to the
CRM1 receptor (29) and with each of the GFP fusion plas-
mids.
As expected, knockdown of the CRM1 receptor had no
effect on the subcellular localization of GFP, whereas a clear
nuclear accumulation of GFPp37 and GFP(1-160) fusion pro-
teins was observed (Fig. 2d). Consistent with the results ob-
tained using LMB, the subcellular localization of the GFP(231-
372) fusion protein was not affected by depletion of the CRM1
receptor (Fig. 2d). At 48 hours posttransfection, a specific and
significant reduction of the expression levels of the CRM1
receptor was confirmed by Western blot analysis, whereas a
nonsilencing control siRNA had no effect on the protein ex-
pression levels (Fig. 2e).
Overall, these results demonstrate that two different path-
ways are responsible for the nuclear export process of full-
length p37 protein: the CRM1-dependent nuclear export path-
way and an unidentified CRM1-independent pathway.
The strength of the nuclear export of the N terminus of p37
protein is similar to that of the C terminus. To assess the
strength of the nuclear export activities of the N- and C-ter-
minal fragments of p37 protein, as well as their relative con-
tribution to the nuclear export of full-length p37 protein, the
Rev(1.4)-GFP nuclear export assay (19) was used. This assay is
based on the expression of fusion proteins, consisting of
Rev(1.4), an export-defective HIV-1 Rev protein mutant, the
sequence to be tested, and GFP (19). The strength of the NESs
is evaluated by analyzing their capacity to promote nuclear
export of the Rev(1.4)-GFP fusion protein.
The Rev(1.4)-GFP fusion protein, which was used as a neg-
ative control for this assay, was localized exclusively in the
nucleus of COS-7 cells, presenting a clear nucleolar accumu-
lation (Fig. 3a and b). Following actinomycin D treatment,
which blocks the nuclear import mediated by the Rev NLS, this
fusion remained nuclear (Fig. 3a and b), further demonstrating
that no NES is present in this construct. Rev(1.4)-NES–GFP,
a fusion protein that contains the Rev NES, which was used as
a positive control for this assay, was localized in the nucleus
and the cytoplasm of transfected cells (Fig. 3a and b). The
number of cells presenting exclusively cytoplasmic localization
was enhanced by ActD treatment (Fig. 3a and b). The cyto-
plasmic localization of the Rev(1.4)-NES–GFP fusion protein
was completely blocked by the addition of leptomycin B (Fig.
3a and b), as expected for a protein that is exported through
the CRM1-dependent nuclear export pathway.
Consistent with previous observations obtained in our labo-
ratory demonstrating that p37 protein is actively exported from
the nucleus (12), full-length p37 protein readily promoted a
relocation of the Rev(1.4)-GFP fusion protein from the nu-
cleus to the cytoplasm of a significant number of cells (Fig. 3a
and b). Upon treatment with ActD, the number of cells pre-
senting exclusively cytoplasmic fluorescence increased signifi-
cantly (Fig. 3a and b). In contrast to what was observed for
Rev(1.4)-NES–GFP, upon LMB treatment, the Rev(1.4)-p37–
GFP fusion protein was still detectable in the cytoplasm of the
majority of cells (93.2%), which is consistent with the involve-
ment of a CRM1-independent pathway in the nuclear export of
p37 protein.
When fused with Rev(1.4)-GFP, both the N- and C-terminal
fragments of p37 protein were able to induce a cytoplasmic
relocation of the fusion protein in a significant number of cells,
which was further increased by ActD treatment (Fig. 3a and b).
Interestingly, distinct results were obtained upon LMB treat-
ment of cells expressing each of these two constructs: the
fusion protein containing the p37(1-160) fragment accumu-
lated inside the nucleus of 68.8% of cells, whereas for the
fusion protein containing the p37(231-372) fragment, no effect
was observed (nuclear in 15.7% of cells) (Fig. 3a and b).
The fusion protein containing the p37(158-234) fragment
remained, under all experimental conditions, exclusively nu-
clear in the majority of cells (Fig. 3a and b), similar to what was
observed for the negative control, further demonstrating that
no NES is present in this fragment.
To facilitate the comparison of the strengths of the nuclear
export processes of the two fragments of p37 protein, a relative
nuclear export activity was assigned to each construct accord-
ing to the NES scoring system developed by Henderson and
Eleftheriou (19). An export rate of 7 denotes a strong NES,
which corresponds to a sequence that is able to induce exclu-
sively cytoplasmic localization of the Rev(1.4)-GFP fusion pro-
tein in 20 to 50% of cells in the absence of ActD and in more
than 80% of cells upon ActD treatment (19).
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As estimated from the results of the cell counts obtained
under the different experimental conditions (Fig. 3b), the
strengths of the nuclear export of p37 protein and that of the
HIV-1 Rev NES are comparable (7) (Fig. 3c), clearly dem-
onstrating that the nuclear export of p37 protein is a strong
process.
Interestingly, the strength of the nuclear export of the N-
terminal fragment of p37 protein (4) is similar to that of the
C-terminal fragment (4) (Fig. 3c), suggesting that the
CRM1-dependent and CRM1-independent nuclear export
pathways may contribute equally to the overall nuclear export
of full-length p37 protein.
The CRM1-dependent nuclear export of the N terminus of
p37 protein is mediated by two independent NESs. To inves-
tigate the location of the NES responsible for the nuclear
export of the N-terminal fragment of p37 protein, the subcel-
lular localization of several GFP-tagged p37 fragments and
deletion mutants was analyzed in Vero cells by confocal fluo-
rescence microscopy.
The GFP(46-234) fusion protein was exported to the cyto-
plasm by a CRM1-dependent mechanism (Fig. 4). A detailed
analysis of the amino acid sequence of this p37 fragment led to
the identification of a leucine-rich sequence between amino
acids 122 and 129 (LEGLDLYL), which constituted a good
candidate to mediate the nuclear export of the N-terminal
fragment of p37 protein. This sequence resembles the well-
characterized, leucine-rich NESs present in cellular and viral
proteins, such as the NESs present in PKI or in the HIV-1 Rev
protein (Fig. 5), which consist of four closely spaced hydro-
phobic amino acids, most often leucine or isoleucine residues.
Surprisingly, a deletion mutant lacking this putative NES
[GFP(46-234)122-129] was still efficiently exported from the
nucleus to the cytoplasm of transfected cells through the
CRM1 pathway (Fig. 4), clearly indicating the existence of an
alternative sequence responsible for the nuclear export of the
p37(46-234) fragment.
Following the systematic analysis of the subcellular localiza-
tion of several other p37 fragments (data not shown), it was
FIG. 3. The strengths of the nuclear export processes of the N and C termini of p37 protein are similar. (a) Full-length p37 protein and three
p37 fragments (1 to 160, 158 to 234, 231 to 372) were fused to an export-deficient mutant of Rev [Rev(1.4)-GFP], and their subcellular distributions
were analyzed in transfected COS-7 cells. Rev(1.4)-NES–GFP, which contains the HIV-1 Rev NES, was used as a positive control. Forty-eight
hours after transfection, all cell samples were incubated with 10 g/ml cycloheximide and either left untreated (CHX), treated with 5 g/ml
actinomycin D (ActD), or treated with 20 ng/ml leptomycin B (LMB) for 3 hours. The subcellular distribution of the different Rev(1.4)-GFP
fusion proteins was examined by confocal fluorescence microscopy (magnification,600), and representative images are shown. (b) The subcellular
localization of each construct is indicated as a percentage of the total number of cells counted. C, exclusively cytoplasmic; N/C, both nuclear and
cytoplasmic; and N, exclusively nuclear. Each experiment was performed at least three times, and approximately 200 cells were counted per
experimental condition. Error bars indicate standard deviations. (c) A scoring scale based on cell counts was used to assign relative export activities
to each of the tested sequences as described by Henderson and Eleftheriou (19). A relative nuclear export strength of 7 denotes a strong NES.
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observed that the deletion mutant lacking amino acids 140 to
159 [GFP(46-234)140-159] was not able to undergo efficient
nuclear export (Fig. 4). By analyzing the nuclear export ability
of two additional deletion mutants [GFP(46-234)150-159 and
GFP(46-234)140-149], the nuclear export sequence was fur-
ther restricted to amino acids 140 to 149 (Fig. 4).
In contrast to GFP(46-234)140-149, the GFP(1-234)140-
149 fusion protein was exported from the nucleus to the cyto-
plasm of transfected cells by a LMB-sensitive nuclear export
pathway (Fig. 4), strongly suggesting the existence of an addi-
tional NES localized between amino acids 1 and 46, which is
also responsible for the nuclear export of the N-terminal frag-
ment of p37 protein. This hypothesis was confirmed by the
observation that the fusion protein GFP(1-46) was exported
from the nucleus to the cytoplasm by the CRM1 pathway (Fig.
4). In this context, the absence of nuclear export of GFP(15-
46) in cells expressing this fusion protein (Fig. 4) demonstrated
that the additional nuclear export signal of the N-terminal
fragment of p37 protein is localized between residues 1 and 14.
As shown in Fig. 4, the GFP(15-234)140-149 deletion mu-
FIG. 4. The nuclear export of the N terminus of p37 protein is mediated by two LMB-sensitive NESs. (a) Schematic representation of the
different N-terminal fragments and deletion mutants of p37 protein and respective subcellular localization in untreated (LMB) or LMB-treated
(LMB) Vero cells. C and N/C indicate that in the majority of transfected cells, the fusion protein being tested presents an exclusively cytoplasmic
or both cytoplasmic and nuclear localization, respectively. (b) Forty-eight hours after Vero cells were transfected with the indicated constructs, the
subcellular distributions of the different GFP fusion proteins were examined in Vero cells by confocal fluorescence microscopy (magnification,
600). The cells were left untreated or treated with LMB (20 ng/ml) at 37°C for 3 hours. Experiments were performed at least three times, and
representative images are shown.
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tant, lacking both amino acid sequences 1 to 14 and 140 to 149,
was distributed throughout the nucleus and cytoplasm of trans-
fected cells. This finding demonstrates that these two indepen-
dently active nuclear export sequences, identified at the N
terminus of p37 protein, are collectively responsible for the
CRM1-dependent nuclear export of this viral protein.
Identification of the NES responsible for the CRM1-inde-
pendent nuclear export of the C terminus of p37 protein. To
investigate the localization of the C-terminal NES of p37 pro-
tein, the subcellular localization of several constructs, obtained
by expanding the p37(158-234) fragment toward the C termi-
nus, was analyzed.
Results from this analysis revealed that the fusion protein
GFP(158-249) is localized exclusively in the cytoplasm (Fig. 6)
and that the fusion protein GFP(158-239) is localized both in
the cell nucleus and in the cytoplasm (Fig. 6), suggesting that
the region between amino acids 239 and 249 is a nuclear export
signal.
As shown in Fig. 6, the fusion protein GFP(251-372) was
localized both in the nucleus and in the cytoplasm of trans-
fected cells, excluding the existence of an additional NES in
the C terminus of p37 protein.
In agreement with these results, the fusion protein
GFP(158-372) was localized exclusively in the cytoplasm of
transfected cells (Fig. 6), whereas its deletion mutant lacking
amino acids 239 to 249 [GFP(158-372)239-249] was distrib-
uted throughout the cytoplasm and nucleus of transfected cells
(Fig. 6) in a pattern similar to that of GFP alone. Overall, these
results demonstrate that a functional NES is localized between
amino acids 239 and 249.
As can be observed in Fig. 6, the nuclear export of the
GFP(158-249) and GFP(158-372) fusion proteins was not af-
fected by LMB treatment. These results clearly indicate that
unlike the two NESs identified in the N-terminal fragment of
p37 protein, the NES identified at the C terminus of p37
protein (amino acids 239 to 249) mediates the nuclear export
of this fragment through a CRM1-independent pathway.
As expected, a mutant in which these three NESs were
deleted (GFPp37NES) accumulated inside the nucleus of
FIG. 5. Comparison of nuclear export signals identified in p37 pro-
tein with well-characterized NESs present in cellular and viral proteins.
NESs identified in PKI (48), MAP kinase phosphatase 3 (MKP-3)
(24), Rev protein from HIV-1 (HIV-1 Rev) (13), and ICP27 protein
from herpes simplex virus type 1 (HSV-1 ICP27) (39), as well as the
three NESs identified in the ASFV p37 protein, are shown. Residues
critical to NES activity are highlighted in bold type. In the consensus
NES sequence, 	 indicates a large hydrophobic residue, such as
leucine, isoleucine, valine, or metionine, and X indicates any amino acid.
FIG. 6. The nuclear export of the C-terminal region of p37 protein is mediated by an LMB-insensitive NES. (a) Schematic illustration of the
different C-terminal fragments and deletion mutants of p37 protein and their subcellular localization in untreated (LMB) or LMB-treated
(LMB) cells. C indicates that the fusion protein presents an exclusively cytoplasmic localization, and N/C indicates that the protein is localized
both in the nucleus and in the cytoplasm of the majority of transfected cells. (b) Forty-eight hours after transfection with the different constructs,
Vero cells were either left untreated or treated for 3 hours with 20 ng/ml LMB, and the subcellular distribution of each fusion protein was analyzed
by confocal fluorescence microscopy (magnification, 600). Experiments were performed at least three times, and representative images are shown.
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transfected cells (Fig. 6), confirming that the three identified
signals are responsible for the nuclear export of p37 protein.
Identification of the amino acids critical to the function of
the three nuclear export signals identified in p37 protein.
Since it has been extensively demonstrated that hydrophobic
amino acids are critical to the CRM1-dependent nuclear ex-
port activity mediated by leucine-rich NESs, the role of such
amino acids in the activity of NES1 and NES2 of p37 protein
was analyzed by site-directed mutagenesis.
As shown in Fig. 7a, point mutation of leucine 3, valine 5,
leucine 8, and leucine 10 of NES1 to alanines (NES1-mut1)
dramatically disrupted the cytoplasmic localization of the
GFP(1-46) fusion protein, demonstrating the importance of
these residues to the activity of NES1. A similar alteration of
the subcellular localization was observed upon mutation of two
(L3A and L8A) of the four hydrophobic amino acids of NES1
(NES1-mut2) (Fig. 7a).
Mutation of the residues isoleucine 140 and valine 146 of
NES2 to alanines (NES2-mut2) caused a redistribution of the
GFP(46-234) fusion protein throughout the nucleus and cyto-
plasm (Fig. 7b), whereas mutations I140A, I143A, V146A, and
M149A of NES2 (NES2-mut1) resulted in an increased nu-
clear accumulation of this fusion protein (Fig. 7b). These re-
sults demonstrate that hydrophobic amino acids are also crit-
ical to the function of NES2, although this signal is not in
agreement with the consensus sequence for leucine-rich NESs
(Fig. 5).
In an approach similar to that used for the nuclear export
activity of NES1 and NES2, the residues essential to the nu-
clear export activity of NES3 were identified by analyzing the
subcellular localization of point mutants of this signal, in which
the hydrophobic amino acids were replaced by alanines. As
shown in Fig. 7c, neither NES3-mut1 nor NES3-mut2 was
efficiently exported from the cell nucleus, as demonstrated by
the fluorescence detected both in the nucleus and in the cyto-
plasm of cells expressing these mutants. Although the nuclear
export activity mediated by NES3 was shown to be CRM1
independent, these results provide clear evidence that hydro-
phobic residues are also crucial to the activity of this signal.
p37 protein is localized in different subcellular compart-
ments during ASFV infection. Aiming at determining whether
p37 protein is actively transported between the nucleus and the
cytoplasm in ASFV-infected Vero cells, the subcellular local-
ization of p37 protein was determined by immunofluorescence
analysis at different times postinfection. To facilitate the anal-
ysis of the subcellular localization of p37 protein, the localiza-
tion of -tubulin, which was used as a cytoplasmic marker, was
also determined.
As can be observed in Fig. 8, at early times postinfection (6
hpi), the ASFV p37 protein is localized in distinct regions
inside the nucleus and dispersed throughout the cytoplasm of
Vero cells. On the other hand, at late times of the infection
cycle (14 hpi), no signal is found in the nucleus and p37 protein
is localized exclusively in the cytoplasm, clearly concentrated in
denominated viral factories, specific regions where viral assem-
bly occurs (Fig. 8). Immunofluorescence results of noninfected
FIG. 7. Hydrophobic amino acids are critical to the nuclear export activity of the three NESs identified in p37 protein. Vero cells were
transiently transfected with the control fragments and point mutants of (a) NES1 (amino acids 2 to 11), (b) NES2 (140 to 149), and (c) NES3 (239
to 247). Hydrophobic residues, which were replaced by alanines (underlined) to generate the different mutants, are shown in bold type. The
subcellular localization of the GFP fusion proteins was determined by confocal fluorescence microscopy (magnification, 600). Experiments were
performed at least three times, and representative images are shown.
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cells (mock), which were used as a negative control, are also
shown for comparison.
The observation of distinct subcellular localizations of p37
protein at early and late times of infection, particularly the
presence of the viral protein inside the nucleus at the initial
stages of the infection cycle and its disappearance from the
nucleus at later times, is in agreement with our results for
transfected cells demonstrating that p37 protein is a nucleocy-
toplasmic shuttling protein. Overall, these results support the
existence of an active p37 transport between the nucleus and
the cytoplasm during ASFV infection.
DISCUSSION
Aiming at identifying the signals responsible for the nuclear
export of the ASFV p37 protein, we investigated the nuclear
export ability of several protein fragments. We report that both
the N- and C-terminal fragments of p37 protein are exported
from the nucleus to the cytoplasm of yeast and mammalian
cells, demonstrating the existence of at least two independently
active nuclear export signals in this protein.
Our results showing that the N-terminal fragment of p37
protein accumulated in the nucleus upon cell treatment with
LMB demonstrated that its nuclear export occurs through the
CRM1 pathway. Interestingly, the nuclear export of the C-
terminal segment of p37 protein was not affected by cell treat-
ment with LMB, indicating that the nuclear export of this p37
fragment occurs via a CRM1-independent nuclear export path-
way. Overall, these results undoubtedly demonstrate that the
nuclear export of p37 protein occurs by the CRM1-dependent
nuclear export pathway as well as by an unidentified CRM1-
independent nuclear export pathway.
Using the Rev(1.4)-GFP nuclear export assay, we were able
to determine that the nuclear export of p37 protein is a strong
process, comparable to that of the Rev protein of HIV-1 (7,
according to the NES scoring system) (19). This finding is in
agreement with previous results obtained in our laboratory
demonstrating that the nuclear export of p37 protein is able to
overcome the nuclear import mediated by the SV40 NLS (12).
Since the nuclear export of full-length p37 protein is LMB
sensitive, it would be reasonable to assume that the nuclear
export mediated by the CRM1 receptor (sensitive to LMB)
would be stronger than the CRM1-independent nuclear export
(insensitive to LMB). However, as determined by the
Rev(1.4)-GFP assay, the strengths of the nuclear exports of the
N- and C-terminal fragments of p37 are equivalent (4), sug-
gesting that the CRM1-dependent and CRM1-independent
FIG. 8. Distinct subcellular localization of p37 protein in ASFV-infected cells at different times postinfection. Vero cells infected with the
BA71V strain of ASFV or mock-infected cells were fixed and processed for immunofluorescence analysis at the indicated times postinfection.
Samples were incubated with a rabbit antiserum raised against the p37 protein and a monoclonal -tubulin antibody, followed by incubation with
secondary antibodies conjugated to Alexa Fluor 488 (green) and Alexa Fluor 594 (red), respectively. Confocal laser scanning images acquired in
green and red channels are presented separately and as a merged image. Experiments were performed at least three times, and representative images
are shown.
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nuclear export pathways contribute equally to the nuclear ex-
port of full-length p37 protein. Nonetheless, it cannot be ex-
cluded that in the context of full-length p37 protein, one of
these pathways may be dominant compared to the other.
Although the nuclear export pathway mediated by the
CRM1 receptor is the most extensively studied, other export
receptors have been identified (34). For example, it has been
shown that in addition to the CRM1 receptor, calreticulin
mediates the nuclear export of protein kinase inhibitor by
interacting with the leucine-rich NES present in PKI (20).
More recently, a new nuclear export receptor was identified,
exportin-7 (31), which was suggested to exhibit broad substrate
specificity, therefore defining a new general nuclear export
pathway. However, the signals that were shown to mediate
nuclear export through this pathway are very different from the
leucine-rich NESs commonly associated with the CRM1-de-
pendent nuclear export pathway. Interestingly, these signals do
not appear to be short linear sequences but rather signals
requiring a specific three-dimensional folding. Moreover, basic
residues were shown to be critical to exportin-7 recruitment.
We have identified and characterized three functional NESs
in p37 protein (Fig. 5). NES1 and NES2, localized in the N
terminus of p37 protein, were shown to powerfully mediate the
export p37 protein from the nucleus to the cytosol by the
LMB-sensitive, and hence CRM1-dependent, nuclear export
pathway. Although NES1 is similar to the NESs identified in
PKI or the HIV-1 Rev protein, NES2 is not in agreement with
the consensus sequence for leucine-rich NESs (Fig. 5). None-
theless, mutation of the hydrophobic residues within both
NESs completely abolished their nuclear export abilities.
Other viral proteins have been described to contain NESs
which, although rich in hydrophobic residues, do not fit the
well-defined consensus for leucine-rich NESs (32, 37). Despite
this lack of homology, these NESs also mediate CRM1-depen-
dent nuclear export.
In addition to the two NESs identified in the N terminus of
p37 protein, a third NES was identified at its C terminus.
Although NES3 does not interact with the CRM1 receptor, the
amino acids that were shown to be critical to its function are
also hydrophobic. Moreover, recent reports have demon-
strated the interaction of proteins bearing leucine-rich NESs
with receptors other than CRM1 (17, 52). It should be stressed
that the characteristics of NES3 are divergent from those that
have been proposed to be required for exportin-7 recruitment,
although the possibility that other motifs are recognized by this
exportin or that p37 protein is most likely exported by an
alternative pathway cannot be excluded. Additional studies are
needed to investigate the detailed mechanism by which the
CRM1-independent nuclear export of p37 protein occurs.
Similar to that of the ASFV p37 protein, which contains
three NESs and is exported through two concurrent pathways,
the nuclear export of other proteins has been demonstrated to
be mediated by more than one NES and to occur through both
the CRM1-dependent and CRM1-independent pathways. Ex-
amples include -catenin, which was reported to contain both
a weak LMB-insensitive NES and a strong LMB-sensitive NES
(17), as well as receptor-interacting protein 3, which contains
two leucine-rich NESs that are responsible for its nuclear ex-
port by the CRM1 pathway and an additional NES that is
involved in the CRM1-independent nuclear export of this pro-
tein (52).
A possible explanation for the existence of three NESs in
p37 protein is that the presence of multiple NESs in proteins,
apparently redundant, constitutes a strategy that ensures suc-
cessful nuclear export of certain proteins of critical function;
an additional hypothesis is that the existence of multiple NESs
in proteins results in an enhanced nuclear export ability, by a
cooperative effect, in a mechanism similar to the one suggested
for the presence of multiple NLSs in proteins (36).
We have previously shown that a fusion protein containing
p37, with a molecular weight above the nuclear pore diffusion
limit, accumulates inside the nucleus when nuclear export is
inhibited (12). Although this finding demonstrates that p37
protein is also imported into the nucleus by an active process,
analysis of p37 protein sequence did not reveal the existence of
sequences with homology to classical NLSs. The best-charac-
terized NLSs consist of a small cluster of basic amino acids,
namely, lysine and arginine residues (23). Nonetheless, a vari-
ety of sequences that have no obvious resemblance to classical
NLSs were also shown to mediate protein nuclear import (8,
50). Alternatively, the binding of p37 protein to some cellular
or viral NLS-containing protein that is recognized by the nu-
clear import machinery may explain how p37 protein is im-
ported into the nucleus.
Whatever the mechanism of nuclear import used by p37
protein, the strong cytoplasmic localization of p37 protein at
the steady state strongly suggests that its nuclear import is less
important than its nuclear export, which occurs through two
different pathways and is mediated by the three NESs charac-
terized in this study.
Considering the importance that nucleocytoplasmic trans-
port of viral proteins may have at an early stage of ASFV
infection, when the nuclear phase of viral DNA replication
occurs, it is reasonable to assume that the nucleocytoplasmic
shuttling activity of p37 protein may play an important role in
the ASFV replication cycle. One possibility is that p37 protein
is involved in the export of the viral genome from the nucleus
to the cytoplasm of infected cells following the brief nuclear
replication phase. This hypothesis is supported by the results of
immunofluorescence studies of ASFV-infected cells described
in the present report, which clearly demonstrate that p37 pro-
tein is localized inside the nucleus at early times postinfection
(6 hpi) and localized exclusively in the cytoplasm at later times
(14 hpi). Additionally, results from in situ hybridization exper-
iments clearly showed colocalization of the viral DNA and p37
protein in specific nuclear regions at early times postinfection
(unpublished data), further supporting this hypothesis.
Although studies in progress aim at further elucidating the
relevance of the nuclear export of p37 protein to the replica-
tion cycle of African swine fever virus, all evidence indicates
that this capacity should be crucial for its biological function, as
stressed by the presence of multiple NESs and of two alterna-
tive pathways for the nuclear export of this protein.
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